RU2006104035A - SOLID MEDICINAL FORM OF DIINDOLYLMETHANE FOR THE TREATMENT OF NEOPLASTIC DISEASES - Google Patents
SOLID MEDICINAL FORM OF DIINDOLYLMETHANE FOR THE TREATMENT OF NEOPLASTIC DISEASES Download PDFInfo
- Publication number
- RU2006104035A RU2006104035A RU2006104035/15A RU2006104035A RU2006104035A RU 2006104035 A RU2006104035 A RU 2006104035A RU 2006104035/15 A RU2006104035/15 A RU 2006104035/15A RU 2006104035 A RU2006104035 A RU 2006104035A RU 2006104035 A RU2006104035 A RU 2006104035A
- Authority
- RU
- Russia
- Prior art keywords
- diindolylmethane
- enteric coating
- poloxamer
- antioxidant
- treatment
- Prior art date
Links
- VFTRKSBEFQDZKX-UHFFFAOYSA-N 3,3'-diindolylmethane Chemical compound C1=CC=C2C(CC=3C4=CC=CC=C4NC=3)=CNC2=C1 VFTRKSBEFQDZKX-UHFFFAOYSA-N 0.000 title claims 3
- TWJAXIHBWPVMIR-UHFFFAOYSA-N diindolylmethane Natural products C1=CC=C2NC(CC=3NC4=CC=CC=C4C=3)=CC2=C1 TWJAXIHBWPVMIR-UHFFFAOYSA-N 0.000 title claims 3
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000001613 neoplastic effect Effects 0.000 title 1
- 239000007787 solid Substances 0.000 title 1
- 239000002702 enteric coating Substances 0.000 claims 3
- 238000009505 enteric coating Methods 0.000 claims 3
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims 2
- 239000003963 antioxidant agent Substances 0.000 claims 2
- 230000003078 antioxidant effect Effects 0.000 claims 2
- 239000011230 binding agent Substances 0.000 claims 2
- 239000000945 filler Substances 0.000 claims 2
- 229960000502 poloxamer Drugs 0.000 claims 2
- 229920001983 poloxamer Polymers 0.000 claims 2
- 239000003381 stabilizer Substances 0.000 claims 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- 239000001736 Calcium glycerylphosphate Substances 0.000 claims 1
- 229920002785 Croscarmellose sodium Polymers 0.000 claims 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 claims 1
- 208000008636 Neoplastic Processes Diseases 0.000 claims 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims 1
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- UHHRFSOMMCWGSO-UHFFFAOYSA-L calcium glycerophosphate Chemical compound [Ca+2].OCC(CO)OP([O-])([O-])=O UHHRFSOMMCWGSO-UHFFFAOYSA-L 0.000 claims 1
- 229940095618 calcium glycerophosphate Drugs 0.000 claims 1
- 235000019299 calcium glycerylphosphate Nutrition 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000011248 coating agent Substances 0.000 claims 1
- 238000000576 coating method Methods 0.000 claims 1
- 229960005168 croscarmellose Drugs 0.000 claims 1
- 239000001767 crosslinked sodium carboxy methyl cellulose Substances 0.000 claims 1
- 239000007884 disintegrant Substances 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 239000000314 lubricant Substances 0.000 claims 1
- 230000001050 lubricating effect Effects 0.000 claims 1
- 229940117841 methacrylic acid copolymer Drugs 0.000 claims 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 claims 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 229910052710 silicon Inorganic materials 0.000 claims 1
- 239000010703 silicon Substances 0.000 claims 1
- 235000010413 sodium alginate Nutrition 0.000 claims 1
- 239000000661 sodium alginate Substances 0.000 claims 1
- 229940005550 sodium alginate Drugs 0.000 claims 1
- 235000017557 sodium bicarbonate Nutrition 0.000 claims 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims 1
- 239000007909 solid dosage form Substances 0.000 claims 1
- 239000000454 talc Substances 0.000 claims 1
- 229910052623 talc Inorganic materials 0.000 claims 1
- 239000004408 titanium dioxide Substances 0.000 claims 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2006104035/15A RU2318509C2 (en) | 2006-02-10 | 2006-02-10 | Diindolylmethane solid medicinal formulation for treatment of neoplastic disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2006104035/15A RU2318509C2 (en) | 2006-02-10 | 2006-02-10 | Diindolylmethane solid medicinal formulation for treatment of neoplastic disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2006104035A true RU2006104035A (en) | 2007-08-27 |
| RU2318509C2 RU2318509C2 (en) | 2008-03-10 |
Family
ID=38596960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2006104035/15A RU2318509C2 (en) | 2006-02-10 | 2006-02-10 | Diindolylmethane solid medicinal formulation for treatment of neoplastic disease |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2318509C2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2409363C9 (en) | 2009-09-18 | 2013-12-10 | Всеволод Иванович Киселев | Pharmaceutical compositions for peroral delivery of diindolylmethane (dim) and methods for application of these compositions |
| RU2419426C1 (en) * | 2010-04-26 | 2011-05-27 | Всеволод Иванович Киселев | Diindolylmethane (dim)-based medication with increased bioaccessebility and its application in treatment of human hyperplastic and inflammatory diseases |
| RU2537025C1 (en) * | 2013-05-28 | 2014-12-27 | Всеволод Иванович Киселев | Diindolylmethane drug preparation and using it for treating influenza and respiratory viral infections |
| RU2601893C1 (en) * | 2015-11-30 | 2016-11-10 | Всеволод Иванович Киселев | Drug preparation based on indole-3-carbinol with increased epigenetic activity |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5838494A (en) * | 1993-01-14 | 1994-08-15 | Cancer Research Campaign Technology Limited | Potentiation of temozolomide in human tumour cells |
| RU2102079C1 (en) * | 1996-11-11 | 1998-01-20 | Юрий Александрович Страхов | Method of treatment of uterus myoma |
| US6001868A (en) * | 1997-05-30 | 1999-12-14 | The Regents Of The University Of California | Indole-3-carbinol (I3C) derivatives and methods |
| US6544564B1 (en) * | 2001-11-27 | 2003-04-08 | Michael Donald Farley | Cytotoxic pharmaceutical composition |
-
2006
- 2006-02-10 RU RU2006104035/15A patent/RU2318509C2/en active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2318509C2 (en) | 2008-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6306436B1 (en) | Stabilized, acid-free formulation for sustained release of bupropion hydrochloride | |
| KR102464646B1 (en) | Formulation of (R)-2-amino-3-phenylpropyl carbamate | |
| JP6061438B2 (en) | Pharmaceutical composition containing diamine derivative | |
| HRP20120633T1 (en) | Delayed release rasagiline formulation | |
| CA2628200A1 (en) | Solid pharmaceutical compositions containing pregabalin | |
| HRP20240231T1 (en) | Pharmaceutical formulations of bruton's tyrosine kinase inhibtor | |
| JP2006516570A5 (en) | ||
| RU2013141534A (en) | L-MENTHOL COMPOSITIONS CONSISTING OF A SET OF PARTICLES AND RELATED METHODS | |
| US9770437B2 (en) | Compositions of eltrombopag | |
| RU2020140867A (en) | CAPSULES WITH SOLUBLE ESTRADIOL FOR INTRAVAGINAL ADMINISTRATION | |
| US20140329781A1 (en) | Methods for treating cardiovascular disorder | |
| CN102300562A (en) | Pharmaceutical composition containing 2-oxo-1-pyrrolidine derivative | |
| US20150025146A1 (en) | Gastroretentive tablets | |
| WO2018064490A1 (en) | Compositions of midodrine and methods of using the same | |
| RU2007148195A (en) | ORAL DOSED FORMS OF O-DESMETHYLVENENLAFXIN SUCCINATE OF INCREASED BIOAVAILABILITY WITH DELAYED DELIVERY | |
| RU2006104035A (en) | SOLID MEDICINAL FORM OF DIINDOLYLMETHANE FOR THE TREATMENT OF NEOPLASTIC DISEASES | |
| AU2016231883B2 (en) | Pharmaceutical compositions of dimethyl fumarate | |
| RU2017114677A (en) | ORAL DECAYING SOLID PHARMACEUTICAL DOSING UNIT CONTAINING CONTROL GENERAL ACTIVITY SUBSTANCE | |
| RU2013103746A (en) | COMBINATION, INCLUDING A) NILOTINIB, B) THR315lle KINASE INHIBITOR | |
| JP2016104729A (en) | Triturated tablet, and method for producing triturated tablet | |
| RU2013126056A (en) | COMPOSITION FOR TREATMENT OF INVERVATION DISORDERS (OPTIONS) | |
| RU2580656C1 (en) | Immediate-release solid dosage form of hydroxychloroquine and method for producing it | |
| RU2008115582A (en) | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PARKINSON'S DISEASE | |
| RU2005140982A (en) | PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF PROLIFERATIVE BREAST DISEASES | |
| RU2018118603A (en) | PHARMACEUTICAL COMPOSITIONS OF DIMETHYLFUMARATE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC41 | Official registration of the transfer of exclusive right |
Effective date: 20180907 |
|
| RH4A | Copy of patent granted that was duplicated for the russian federation |
Effective date: 20190606 |